Annals of Allergy, Asthma, & Immunology Editor-in-Chief
@annalseditor.bsky.social
Editor-in-Chief for the Annals of Allergy, Asthma & Immunology, a premiere Allergy and Immunology journal. Our journal is dedicated to promoting the best science to support the care provided by practicing clinicians. Read and publish in Annals!
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
One of the first-line options for long term prophylaxis in HAE patients is lanadelumab, a fully human monoclonal antibody inhibiting plasma kallikrein. The authors report findings from 2 prospective, noninterventional, multicenter phase 4 studies. Learn more: https://loom.ly/gMx757w
November 18, 2025 at 8:10 PM
One of the first-line options for long term prophylaxis in HAE patients is lanadelumab, a fully human monoclonal antibody inhibiting plasma kallikrein. The authors report findings from 2 prospective, noninterventional, multicenter phase 4 studies. Learn more: https://loom.ly/gMx757w
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Ready to submit an article? Share your expertise and submit it here: https://loom.ly/uBd7yU4
Editorial Manager®
Full-Function Web-Enabled Manuscript Submission and Tracking System for Peer Review
www.editorialmanager.com
November 13, 2025 at 3:05 PM
Ready to submit an article? Share your expertise and submit it here: https://loom.ly/uBd7yU4
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
This review discusses drug hypersensitivity reactions in mastocytosis, focusing on the most frequent drug triggers and their management. A history-driven, evidence-based approach allows most patients to be treated effectively without unnecessary drug avoidance. https://loom.ly/nlkd5RY
November 11, 2025 at 3:06 PM
This review discusses drug hypersensitivity reactions in mastocytosis, focusing on the most frequent drug triggers and their management. A history-driven, evidence-based approach allows most patients to be treated effectively without unnecessary drug avoidance. https://loom.ly/nlkd5RY
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Chronic rhinosinusitis (CRS) is a common condition evaluated by the allergist-immunologist. Here are 10 things you should know about this common and important condition. https://loom.ly/JT_dPHQ
November 6, 2025 at 3:06 PM
Chronic rhinosinusitis (CRS) is a common condition evaluated by the allergist-immunologist. Here are 10 things you should know about this common and important condition. https://loom.ly/JT_dPHQ
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Several new agents have received Food and Drug Administration approval, expanding therapeutic options for patients. These innovations represent a shift toward personalized atopic dermatitis management. Learn more: https://loom.ly/hszCE8g
November 4, 2025 at 3:05 PM
Several new agents have received Food and Drug Administration approval, expanding therapeutic options for patients. These innovations represent a shift toward personalized atopic dermatitis management. Learn more: https://loom.ly/hszCE8g
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Do you want to write an article for Annals? Here are our guidelines: www.annallergy.org/content/auth...
Information for Authors: Annals of Allergy, Asthma & Immunology
www.annallergy.org
October 30, 2025 at 2:20 PM
Do you want to write an article for Annals? Here are our guidelines: www.annallergy.org/content/auth...
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Earn CME credit with Annals' CME online exams! Read an article in Annals, then take an exam for CME credit! Learn more: https://loom.ly/h7upvqk
Earn CME with Annals
Annals of Allergy, Asthma & Immunology offers the opportunity to earn CME through some of its articles. Learn more.
www.annallergy.org
October 23, 2025 at 2:05 PM
Earn CME credit with Annals' CME online exams! Read an article in Annals, then take an exam for CME credit! Learn more: https://loom.ly/h7upvqk
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Did you know Annals features collections of articles based on topic? Asthma, Clinical Practice, Drug Allergy, Immunodeficiency, Rhinosinusitis, and more! Access them in the Collections area about halfway down the Annals homepage: https://loom.ly/qDK5bcY
Collections
Read more about Collections at Annals of Allergy, Asthma & Immunology
www.annallergy.org
October 21, 2025 at 8:30 PM
Did you know Annals features collections of articles based on topic? Asthma, Clinical Practice, Drug Allergy, Immunodeficiency, Rhinosinusitis, and more! Access them in the Collections area about halfway down the Annals homepage: https://loom.ly/qDK5bcY
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
How do you systematically synthesize the benefits and harms of triple therapy (ICS/LABA/long-acting muscarinic antagonists) compared with dual therapy (ICS/LABA) for asthma management across key subpopulations? Find out here: https://loom.ly/C3UpA6E
Triple therapy vs dual inhaler therapy for moderate-to-severe asthma
An updated systematic review and meta-analysis
www.annallergy.org
October 16, 2025 at 2:05 PM
How do you systematically synthesize the benefits and harms of triple therapy (ICS/LABA/long-acting muscarinic antagonists) compared with dual therapy (ICS/LABA) for asthma management across key subpopulations? Find out here: https://loom.ly/C3UpA6E
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Two respiratory viruses associated with most recurrent wheeze and asthma development are respiratory syncytial virus (RSV) and rhinovirus (RV). This review evaluates the roles these 2 viruses play in the development of wheeze and asthma. https://loom.ly/hDm2aaI
The usual suspects
Respiratory syncytial virus and rhinovirus drive asthma development and exacerbation
www.annallergy.org
October 14, 2025 at 2:05 PM
Two respiratory viruses associated with most recurrent wheeze and asthma development are respiratory syncytial virus (RSV) and rhinovirus (RV). This review evaluates the roles these 2 viruses play in the development of wheeze and asthma. https://loom.ly/hDm2aaI
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Come to this years American College of Allergy, Asthma & Immunology meeting - it is going to be great! I'll be there presenting the best from Annals from the last year. Hope to see you in Orlando! (register at annualmeeting.acaai.org/2025 )
@annalsacaai.bsky.social #ACAAI25
@annalsacaai.bsky.social #ACAAI25
October 8, 2025 at 3:47 PM
Come to this years American College of Allergy, Asthma & Immunology meeting - it is going to be great! I'll be there presenting the best from Annals from the last year. Hope to see you in Orlando! (register at annualmeeting.acaai.org/2025 )
@annalsacaai.bsky.social #ACAAI25
@annalsacaai.bsky.social #ACAAI25
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Who's this year's winner of the "Pathy" award? (wink, wink) Who was nominated? Who won? Find out in Marginal Zone, only in Annals of Allergy, Asthma & Immunology. https://loom.ly/vx0R1C8
“And the Pathy goes to…”
Erin L. Reigh, MD, MS
www.annallergy.org
October 9, 2025 at 2:04 PM
Who's this year's winner of the "Pathy" award? (wink, wink) Who was nominated? Who won? Find out in Marginal Zone, only in Annals of Allergy, Asthma & Immunology. https://loom.ly/vx0R1C8
Come to this years American College of Allergy, Asthma & Immunology meeting - it is going to be great! I'll be there presenting the best from Annals from the last year. Hope to see you in Orlando! (register at annualmeeting.acaai.org/2025 )
@annalsacaai.bsky.social #ACAAI25
@annalsacaai.bsky.social #ACAAI25
October 8, 2025 at 3:47 PM
Come to this years American College of Allergy, Asthma & Immunology meeting - it is going to be great! I'll be there presenting the best from Annals from the last year. Hope to see you in Orlando! (register at annualmeeting.acaai.org/2025 )
@annalsacaai.bsky.social #ACAAI25
@annalsacaai.bsky.social #ACAAI25
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Asthma disproportionately affects non–English-speaking populations, with language barriers contributing to worse health outcomes, including increased emergency department visits and hospitalizations. Find out what health systems can do to reduce disparities. https://loom.ly/oUepsUM
Impact of language barriers on pulmonary function and asthma control
Language barriers significantly impact asthma management
www.annallergy.org
October 7, 2025 at 2:05 PM
Asthma disproportionately affects non–English-speaking populations, with language barriers contributing to worse health outcomes, including increased emergency department visits and hospitalizations. Find out what health systems can do to reduce disparities. https://loom.ly/oUepsUM
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Student health center or clinic administration of subcutaneous immunotherapy (SCIT) while at college/university is not well studied. This study aimed to clarify SCIT administration on campus both from the Allergist’s and student health center's perspectives. https://loom.ly/7DZZCHM
Subcutaneous immunotherapy administration on college campuses
Two exploratory surveys of Florida allergists and student health
www.annallergy.org
October 2, 2025 at 2:05 PM
Student health center or clinic administration of subcutaneous immunotherapy (SCIT) while at college/university is not well studied. This study aimed to clarify SCIT administration on campus both from the Allergist’s and student health center's perspectives. https://loom.ly/7DZZCHM
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
This study hoped to better understand the experiences of college students with and without food allergy (FA) to determine ways to improve safety and quality of life for those with FA. Were they successful? Find out: https://loom.ly/LRKese4
Determining avenues for improved food allergy support and safety on college campuses
Food Allergy (FA) is a chronic disease with public health importance affecting an estimated 1 in 13 children and 1 in 10 adults.
www.annallergy.org
September 30, 2025 at 2:05 PM
This study hoped to better understand the experiences of college students with and without food allergy (FA) to determine ways to improve safety and quality of life for those with FA. Were they successful? Find out: https://loom.ly/LRKese4
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Childhood asthma is more common in boys; however, its prevalence decreases more significantly in boys than in girls during puberty. Sex differences in urinary mast cell mediators remain unreported despite known sex-specific variations in eicosanoid pathways. https://loom.ly/exA7i_g
Sex differences in urinary mast cell mediators
Implications for diagnosing atopic and mast cell disorders
www.annallergy.org
September 25, 2025 at 2:05 PM
Childhood asthma is more common in boys; however, its prevalence decreases more significantly in boys than in girls during puberty. Sex differences in urinary mast cell mediators remain unreported despite known sex-specific variations in eicosanoid pathways. https://loom.ly/exA7i_g
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Other viruses beyond respiratory syncytial virus (RSV) and rhinovirus play a significant but underappreciated role in asthma inception and exacerbations. Learn more about these other respiratory bandits and earn CME: https://loom.ly/Dj3KirY
Beyond respiratory syncytial virus and rhinovirus
The other viral respiratory bandits
www.annallergy.org
September 23, 2025 at 2:05 PM
Other viruses beyond respiratory syncytial virus (RSV) and rhinovirus play a significant but underappreciated role in asthma inception and exacerbations. Learn more about these other respiratory bandits and earn CME: https://loom.ly/Dj3KirY
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Wonder what your colleagues are reading in Annals? Take a look at the Most Read (Last 30 Days) section of the Annals homepage and find out! www.annallergy.org
Home Page: Annals of Allergy, Asthma & Immunology
www.annallergy.org
September 18, 2025 at 3:06 PM
Wonder what your colleagues are reading in Annals? Take a look at the Most Read (Last 30 Days) section of the Annals homepage and find out! www.annallergy.org
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Peanut has been implicated as the leading or among the leading causes of fatal anaphylactic reactions. Guidance emphasizes the importance of individualizing treatment and the potential for immunotherapy and omalizumab. www.annallergy.org/article/S108...
Efficacy and safety of epicutaneous immunotherapy in children with peanut allergy with atopic comorbidities
There is a high prevalence rate of atopic comorbidities, including atopic dermatitis
(AD), asthma, and concomitant food allergy (CFA), in children with peanut allergy.
www.annallergy.org
September 16, 2025 at 2:08 PM
Peanut has been implicated as the leading or among the leading causes of fatal anaphylactic reactions. Guidance emphasizes the importance of individualizing treatment and the potential for immunotherapy and omalizumab. www.annallergy.org/article/S108...
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
The inclusion of tahini lip dose challenge may help improve diagnostic accuracy in the evaluation of sesame allergy, particularly in identifying patients at high/low risk. Learn more: www.annallergy.org/article/S108...
Predicting severe and early-onset reactions with the tahini-lip dose challenge
Tahini, a sesame seed paste, is often used in skin prick tests (SPTs) and oral food
challenges (OFCs) to diagnose sesame allergy, although OFCs are limited owing to resource
demands and the inherent r...
www.annallergy.org
September 11, 2025 at 2:22 PM
The inclusion of tahini lip dose challenge may help improve diagnostic accuracy in the evaluation of sesame allergy, particularly in identifying patients at high/low risk. Learn more: www.annallergy.org/article/S108...
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
The September 2025 issue of Annals of Allergy, Asthma & Immunology focuses on respiratory viruses and asthma. Read the highlights: college.acaai.org/the-septembe...
The September issue of Annals focuses on respiratory viruses and asthma - ACAAI Member
Do you know what the National Asthma Control Program (NACP) is and why it is important to asthma care in the United States?
college.acaai.org
September 11, 2025 at 4:18 PM
The September 2025 issue of Annals of Allergy, Asthma & Immunology focuses on respiratory viruses and asthma. Read the highlights: college.acaai.org/the-septembe...
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Decreasing long-term air pollution exposure and increasing allergen sensitization are associated with higher type 2/non-type 2 CRSwNP ratio, highlighting the role of environmental factors in endotype shifting. www.annallergy.org/article/S108...
Association of long-term air pollution and allergen exposure with endotype shift in chronic rhinosinusitis with nasal polyps
Chronic rhinosinusitis with nasal polyp (CRSwNP) is classified into type 2 and non-type
2 inflammation based on mucosal cytokine level. For 20 years, the type 2/non-type
2 ratio has increased, potenti...
www.annallergy.org
September 9, 2025 at 1:47 PM
Decreasing long-term air pollution exposure and increasing allergen sensitization are associated with higher type 2/non-type 2 CRSwNP ratio, highlighting the role of environmental factors in endotype shifting. www.annallergy.org/article/S108...
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
Any therapy should meet 3 criteria—necessity, safety, and effectiveness. Only by continuing to revisit these are we able to provide the right care, at the right time, every time. Read "Your Money or Your Life!" www.annallergy.org/article/S108...
Your money or your life!
In the classic radio comedy routine, Jack Benny, a comedian known for his comic timing,
deadpan humor, and penny-pinching ways, is faced with a weapon-holding robber who
says, “Your money or your life...
www.annallergy.org
September 4, 2025 at 1:51 PM
Any therapy should meet 3 criteria—necessity, safety, and effectiveness. Only by continuing to revisit these are we able to provide the right care, at the right time, every time. Read "Your Money or Your Life!" www.annallergy.org/article/S108...
Reposted by Annals of Allergy, Asthma, & Immunology Editor-in-Chief
The most recent consensus guidelines recommend treating eosinophilic esophagitis with either proton pump inhibitors, swallowed topical steroids, diet elimination, or dupilumab. Learn more/earn CME: www.annallergy.org/article/S108...
Future of therapy and monitoring for eosinophilic esophagitis and eosinophilic gastrointestinal diseases
Eosinophilic gastrointestinal disorders, including eosinophilic esophagitis, are chronic
TH2-mediated diseases. Establishing a diagnosis and initiating treatment are crucial
to limit disease progressi...
www.annallergy.org
September 2, 2025 at 2:05 PM
The most recent consensus guidelines recommend treating eosinophilic esophagitis with either proton pump inhibitors, swallowed topical steroids, diet elimination, or dupilumab. Learn more/earn CME: www.annallergy.org/article/S108...